- Home
- ACM vs ALKS Comparison
ACM vs ALKS Comparison
Compare ACM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACM | ALKS |
|---|---|---|
| Founded | 1980 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.7B |
| IPO Year | 2007 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ACM | ALKS |
|---|---|---|
| Price | $74.66 | $49.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $131.30 | $43.43 |
| AVG Volume (30 Days) | 1.4M | ★ 1.8M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ 42.71 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | ★ $16,139,622,000.00 | $1,475,899,000.00 |
| Revenue This Year | N/A | $24.26 |
| Revenue Next Year | $6.06 | $4.47 |
| P/E Ratio | $37.12 | ★ N/A |
| Revenue Growth | ★ 0.21 | N/A |
| 52 Week Low | $66.28 | $25.17 |
| 52 Week High | $135.52 | $55.67 |
Technical Indicators
Market Signals| Indicator | ACM | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 62.28 | 48.17 |
| Support Level | $67.49 | $27.78 |
| Resistance Level | $86.74 | $54.77 |
| Average True Range (ATR) | 1.99 | 1.90 |
| MACD | 0.69 | -0.75 |
| Stochastic Oscillator | 89.97 | 37.09 |
Price Performance
Historical ComparisonAbout ACM AECOM
Aecom is one of the largest global providers of advisory, design, and engineering services. It serves a broad spectrum of end markets, including water, transportation, and environment. Based in Dallas, Aecom employs 51,000 people. The company generated $16.1 billion in sales in fiscal 2025.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.